PubMed=23796475; DOI=10.1016/j.jhep.2013.06.010; PMCID=PMC3805787
Tamar Kapanadze, Jaba Gamrekelashvili, Chi Ma, Carmen Chan, Fei Zhao, Stephen M. Hewitt, Lars Zender, Veena Kapoor, Dean W. Felsher, Michael Peter Manns, Firouzeh Korangy, Tim F. Greten;
Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.
J. Hepatol. 59:1007-1013(2013)

DOI=10.5282/edoc.26548
Martina Messner;
Sorafenib resistance of hepatocellular carcinoma: antibiotics second- line to sorafenib therapy inhibit mitochondrial biogenesis and prevent tumor growth resumption.
Thesis PhD (2020); Ludwig Maximilians University of Munich; Munich; Germany

PubMed=32652772; DOI=10.1096/fj.202001128R
Martina Messner, Sabine Schmitt, Maximilian Alexander Ardelt, Thomas Frohlich, Martin Muller, Helmut Pein, Petra Huber-Cantonati, Carina Ortler, Lars M. Koenig, Lena Zobel, Andreas Koeberle ...Show all 18 authors... , Georg J. Arnold, Simon Rothenfusser, Alexandra K. Kiemer, Alexander L. Gerbes, Hans Zischka, Angelika M. Vollmar, Johanna Pachmayr; Show fewer authors
Metabolic implication of tigecycline as an efficacious second-line treatment for sorafenib-resistant hepatocellular carcinoma.
FASEB J. 34:11860-11882(2020)